Experimental Methods

Preparation of complex I and AOX
Complex I was prepared from Bos taurus (bovine) heart mitochondria using the method of Sharpley et al. [1] except that the phospholipids present in the Q-sepharose chromatography buffers (20 mM Tris-HCl pH 7.55, 10 % ethylene glycol, 0.2% n-dodecyl-β-D-maltoside (DDM, Anatrace) and 2 mM EDTA) were 25 µg mL -1 of B. taurus heart cardiolipin (CL), phosphatidylcholine (PC) and phosphatidylethanolamine (PE) (Avanti Polar Lipids Inc.), and size exclusion chromatography was carried out using a 24 mL Superose-6 Increase column (GE Healthcare).
The alternative oxidase from Trypanosoma brucei brucei (AOX) was over-expressed in
Escherichia coli strain FN102/pTbAO [2, 3] . The FN102 strain is auxotrophic for 5-aminolevulinic acid as it lacks the glutamyl-tRNA reductase (gene hemA) required for its production in the first step of E. coli heme biosynthesis; [4] the inability to produce heme prevents formation of the cytochrome bd quinol oxidase. FN102/pTbAO cells were plated onto LB supplemented with 100 into a common 5 mL aliquot. The exchange removes the 5-aminolevulinic acid required for heme synthesis [4] and introduces the iron required for AOX over-expression. The cells were then used to innoculate eight 1 L cultures of the same supplemented medium; the cultures were incubated aerobically at 30 ˚C for ~6 hours (until A 600 reached ~0.6), 100 µM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to induce AOX expression, and the cultures were incubated aerobically at 30 ˚C overnight.
All steps from hereon were carried out at 4 ˚C. The cells, typically 20 g, were harvested by centrifugation and resuspended to 10 mL/g in buffer comprising 50 mM Tris-HCl (pH 7.5); a protease inhibitor cocktail (Roche, 4 tablets per 200 mL), ~500 U per 200 mL of benzonase and 1 mM MgSO 4 were added. Then, the cells were disrupted using a Constant Systems Ltd cell disruptor (one pass at 15 kpsi and two at 30 kpsi), and the cell debris removed by a slow-speed centrifugation (15 min., 8300 x g). The membrane fragments were collected using a high-speed centrifugation (80 min., 160,000 x g), resuspended to 12 mg mL -1 (typically 20 mL) in the same buffer, and snap frozen in liquid nitrogen for storage if required. The membrane proteins were solubilized by addition of an equal volume of solution containing 40% glycerol, 400 mM MgSO 4 and 2.8% octylglucoside, stirred for 1 hour, and centrifuged (30 min., 165,000 x g). The supernatant was filtered, then mixed with TALON cobalt metal affinity resin (Clontech, pre-equilibrated in 50 mM Tris-HCl (pH 7.3), 20% glycerol, 100 mM MgSO 4 , 1.4% octyl-glucoside) in a ratio of 5:1 supernatant:sedimented resin and agitated gently for 45 min. [2] Then, the mixture was centrifuged (5 min., 1000 x g), the supernatant discarded, and the resin washed twice with five volumes of chromatography buffer (20 mM Tris-HCl (pH 7.3), 20% glycerol, 50 mM MgSO 4 , and 0.042 % DDM) supplemented with 20 mM imidazole. Following the final centrifugation the resin was resuspended using two volumes of the same buffer, poured into an XK50 column casing (GE Healthcare) and allowed to settle. The column was assembled, transferred to an Äkta Prime Plus FPLC (GE Healthcare) and washed at 2.5 mL min -1 in the same buffer until A 280 reached the baseline. The column was washed again with chromatography buffer supplemented with 135 mM imidazole and 80 mM NaCl, before AOX was eluted using chromatography buffer supplemented with 250 mM imidazole and 160 mM NaCl. AOX-containing fractions were pooled, concentrated ten-fold to ~1.3 mg mL -1 using a 30 KDa molecular weight cut-off centrifugal filter (Amicon), and dialysed against 2 L of chromatography buffer supplemented with 160 mM NaCl for 5 hours, to remove the imidazole. The final product was aliquoted and snap frozen in liquid nitrogen for storage. Typically, ~8 mg of AOX were obtained from 8 L of cell culture, and the purity was estimated to be 95% by SDS-PAGE analyses.
Preparation of complex I:AOX:Q 10 proteoliposomes
Proteoliposomes were prepared using a protocol adapted from that used previously to reconsitute complex I [5] . First, stock solutions of 25 mg mL min., then 100 µL of sedimented SM2 Biobeads (Bio-Rad Laboratories Ltd.) were added and the mixture agitated gently for 4 hours, with a further 100 µL of Biobeads added after each hour. The mixture was passed through an empty micro bio-spin column (Bio-Rad Laboratories Ltd.) to remove the Biobeads, then centrifuged (45 min., 57,500 x g) to collect the proteoliposomes.
Following resuspension in 100 µL of proteoliposome buffer the yield was typically 200 µL at ~1.5 mg protein mL -1 . Activity assays were carried out on freshly prepared material, as the activity was observed to decrease by ~25% upon each freeze-thaw cycle.
Analytical methods
Total Q 10 contents were quantified spectroscopically under anaerobic conditions, by the change in absorbance observed upon addition of 1.5 or 2 mM KBH 4 at 275 nm (ε ox-red = 12.9 mM -1 cm -1 ); [6] when necessary, 1% SDS was added to minimize light scattering. Total phospholipid contents were determined using the Ames method. [7] 100 µL of each sample (at several different dilutions up to for the fact that each PC or PE contributes one orthophosphate, whereas each CL contributes two.
Protein concentrations in Q 10 PLs were determined using the Pierce bicinchoninic acid (BCA) assay.
Complex I was quantified using the rate of NADH:APAD + oxidoreduction (measured at 400-450 nm (ε = 3.16 mM -1 cm -1 ) with 100 µM NADH and 500 µM APAD + ) [8] with Q 10 reduction by complex I inhibited with 1 µM piericidin A and 15 µg mL -1 alamethicin (a pore forming antibiotic [9] ) to activate all the complexes I. The AOX concentration was taken to be the difference in the total protein and complex I concentrations. Density gradient centrifugation used a glycerol gradient of 2.5−25 % (1.004−1.060 g mL -1 ) in proteoliposome buffer; samples were applied to the top of the gradient and centrifuged for 80 minutes at 310,000 x g.
Catalytic activity measurements
All catalytic activity assays were carried out at 32 ˚C in solutions containing 10 mM Tris-SO 4 (pH 7.5) and 50 mM KCl. Complex I and AOX were inhibited, when required, by 1 µM piericidin A or 1 µM ascofuranone, [3, 10] respectively. Rates of NADH:O 2 oxidoreduction were measured spectroscopically at 340-380 nm (ε NADH = 4.81 mM -1 cm -1 ) using a Spectra max 348 plus 96-well plate reader (Molecular Devices), initiated with 200 µM NADH. NADH:DQ oxidoreduction was measured similarly using 200 µM NADH and 100 µM DQ (added from an DMSO stock solution),
with AOX inhibited by 1 µM ascofuranone. Fluorescence measurements were carried out in an RF-5301PC spectrofluorometer (Shimadzu). The fluorescent dye 9-amino-6-chloro-2-methoxyacridine (ACMA, excitation at 419 nm and emission at 484 nm [11] ) was used to monitor the formation of ∆pH in the presence of 75 mM KNO 3 with nitrate acting as a permeant ion to diminish ∆ψ and allow ∆pH to take the full value of ∆p. The amounts of each component added at the start of the preparation were 0. Crane et al. [12] SMPs (B. taurus heart) 275 nm absorbance 2.7 5.8 1 Norling et al. [13] SMPs (B. taurus heart) 275 nm absorbance 6 -8 12.8 -17.1 1 Narabayashi et al. [14] SMPs (B. taurus heart) 275 nm absorbance 3.4 -3.98 7.2 -8.5 1 Suzuki and Ozawa [15] Mitochondria (B. taurus heart) 275 nm absorbance 3.0 n.d.
Estornell et al. [16] Mitochondria (B. taurus heart) HPLC 2.4 ± 1 n.d. 2. Due to the complexity of the membrane composition the Q 10 was extracted using 2:5 (v:v)
ethanol:n-hexane [17] before spectroscopic quantification.
